Prelude Therapeutics (PRLD) P/E (2021 - 2026)
Prelude Therapeutics (PRLD) P/E from Jun 30, 2021 to Jul 20, 2026. The TTM Prelude Therapeutics (PRLD) P/E is -3.79. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Prelude Therapeutics (PRLD)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.79 | +71.66% |
| 2025 | -2.21 | +162.49% |
| 2024 | -0.84 | -62.40% |
| 2023 | -2.24 | -19.91% |
| 2022 | -2.80 | -75.82% |
| 2021 | -11.56 | N/A |
Comparison Prelude Therapeutics (PRLD) P/E with competitors
Prelude Therapeutics (PRLD) P/E is -3.79.